Scientists discover that Candida albicans, overly abundant in people with alcohol use disorder, triggers immune response that alters dopamine signaling in mice.
From the lab bench to patient care, Peter Gwynne’s research at TUSM is advancing the fight against Lyme disease with critical diagnostics and collaborative science.